Reproductive endocrinology. Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist

By Ragni Guido   Vegetti Walter   Baroni Elena   Colombo Michela   Arnoldi Mariangela   Lombroso Giancarlo  

Human Reproduction, Vol. 16, Iss. 11, 2001-11 ,pp. : 2258-2262

Oxford University Press

Access to resources Recommend Favorite

Infertility. Continuous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF

By Fujii Shunsaku   Sato Shigemi   Fukui Atsushi   Kimura Hidetaka   Kasai Goichiro  

Human Reproduction, Vol. 16, Iss. 8, 2001-08 ,pp. : 1671-1675

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles

By Albano C.  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1426-1430

Oxford University Press

Access to resources Recommend Favorite

Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?

By Lin Y  

Human Reproduction, Vol. 14, Iss. 4, 1999-04 ,pp. : 885-888

Oxford University Press

Access to resources Recommend Favorite

Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase

By Ben-Arie A.   Weissman A.   Shoham Z.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1146-1148

Oxford University Press

Access to resources Recommend Favorite